Fibromyalgia During the COVID-19 Pandemic

NCT04422522 | Unknown

• 1 other identifier: AAGH-01
• Study Type: observational
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

On 12 January 2020, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan City, Hubei Province, China, which was reported to the WHO on 31 December 2019. There is evidence of a high prevalence of psychiatric comorbidities in Fibromyalgia (FM )(especially depression, anxiety, post-traumatic stress disorder), which are associated with a worse clinical profile. In these challenging times of COVID-19, anxiety increased among the general population. Fibromyalgia patients are more at risk of developing anxiety in these difficult times. This might result in more frequent visits to the rheumatology clinics with an exacerbation of their chronic pain syndrome.

Conditions

Fibromyalgia, Primary

Outcome Measures

Primary Outcomes (1)

• Number of FM patients

  Number of FM patients in the rheumatology outpatient clinics during the COVID-19 lockdown period (2020)

  two months

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients attending the rheumatology outpatients clinics (OPD) during the COVID-19 lockdown period (2020)

You may qualify if:

• Patients aged \> 18 year
• Diagnosis of primary fibromyalgia
• Newly diagnosed and follow up patients are included
• Patients who have physically attended the rheumatology clinic during the study period.

You may not qualify if:

• Patients aged \< 18-year-old
• Patients with inflammatory arthritis and associated FM (Secondary FM)
• Patients who didn't physically attend the rheumatology clinics (Those who used Phone calls and other telemedicine platforms).

Sponsors & Collaborators

• Al-Azhar University: lead

Study Sites (1)

Al-Azhar Faculty of medicine, Rheumatology Department

Cairo, 11311, Egypt

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases

Study Officials

• Ahmed Abogamal

  Al-Azhar Faculty of medicine- Cairo

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: June 7, 2020
• First Posted: June 9, 2020
• Study Start: March 15, 2020
• Primary Completion: May 15, 2020
• Study Completion: June 30, 2020
• Last Updated: June 11, 2020

Record last verified: 2020-06

Locations

EG (1)